DRUGS & AGING
Scope & Guideline
Transforming drug therapies to enhance quality of life in older adults.
Introduction
Aims and Scopes
- Geriatric Pharmacotherapy:
Research dedicated to understanding the pharmacokinetics and pharmacodynamics of drugs in older adults, including how aging affects drug metabolism and response. - Polypharmacy and Deprescribing:
Focused studies on the prevalence and effects of polypharmacy in older adults, including strategies for deprescribing potentially inappropriate medications to improve patient outcomes. - Chronic Disease Management:
Investigations into the management of chronic conditions prevalent among older adults, such as diabetes, hypertension, and cardiovascular diseases, with an emphasis on tailored pharmacological interventions. - Adverse Drug Reactions and Drug Interactions:
Research aimed at identifying and mitigating adverse drug reactions and interactions, especially in the context of multimorbidity and polypharmacy. - Quality of Life and Patient-Centered Care:
Studies that explore the impact of pharmacotherapy on the quality of life, emphasizing patient perspectives and outcomes in the context of aging. - Innovative Therapeutics:
Research into newer therapeutic agents and treatment modalities, including biologics and targeted therapies, specifically for older populations.
Trending and Emerging
- Digital Health and Telemedicine:
An increasing number of studies are focusing on the role of digital tools and telemedicine in managing medications and health outcomes for older adults, highlighting the need for innovative approaches in a rapidly changing healthcare environment. - Patient-Reported Outcomes and Quality of Life:
There is a growing emphasis on incorporating patient-reported outcomes in research, reflecting a trend towards more holistic approaches to treatment that prioritize the patient's perspective on their health and medication. - Pharmacogenomics in Aging:
Emerging interest in pharmacogenomic studies to personalize medication regimens for older adults, aiming to optimize therapeutic efficacy while minimizing adverse effects. - Use of Cannabis and Cannabinoids:
Research on the use of medical cannabis and cannabinoids among older adults is gaining traction, particularly in relation to pain management and quality of life improvements. - Focus on Frailty and Comprehensive Geriatric Assessment:
An increasing number of studies are honing in on frailty as a critical factor in medication management, advocating for comprehensive geriatric assessments to tailor pharmacological treatments.
Declining or Waning
- Anticholinergic Burden Studies:
While still relevant, there has been a noticeable decrease in dedicated studies focusing solely on anticholinergic burden, suggesting a potential shift towards broader polypharmacy and deprescribing discussions. - Traditional Pain Management Approaches:
Research centered around traditional pain management strategies, particularly opioid use, has seen reduced focus, likely due to increasing scrutiny over opioid prescribing and a shift towards non-pharmacological management. - Longitudinal Studies of Aging and Medication Use:
Fewer long-term studies tracking medication use and outcomes in aging populations indicate a potential waning interest in longitudinal methodologies in favor of more immediate, intervention-focused research.
Similar Journals
Canadian Geriatrics Journal
Transforming care through groundbreaking research in geriatrics.Canadian Geriatrics Journal, published by MULTIMED INC, is a prominent platform dedicated to advancing the field of geriatrics and gerontology. With its esteemed status as a Q2 journal in both Geriatrics and Gerontology categories for 2023, it ranks favorably within the academic community, holding a 73rd percentile in Nursing Gerontology and a 59th percentile in Medicine Geriatrics and Gerontology according to Scopus metrics. Since its inception in 2011, the journal has aimed to foster innovation and disseminate pivotal research that addresses the complexities of aging populations. Researchers, healthcare professionals, and students interested in the intricacies of geriatric care will find a wealth of open-access resources that contribute significantly to enhancing practice and care methodologies in Canada and beyond. With its address located at 66 Martin St, Toronto, ON L9T 2R2, Canada, the journal stands as a vital resource for stakeholders in the geriatric field.
Clinical Interventions in Aging
Transforming Aging with Evidence-Based SolutionsClinical Interventions in Aging is a premier Open Access journal published by DOVE MEDICAL PRESS LTD that has been at the forefront of geriatric research since its inception in 2006. With its core focus on innovative interventions and evidence-based practices to enhance the quality of life for the elderly, this journal serves as a vital resource for researchers, healthcare professionals, and students in the fields of geriatrics and gerontology. The journal boasts a commendable impact factor, achieving a Q2 ranking in Geriatrics and Gerontology and a Q1 ranking in Medicine (miscellaneous) as of 2023, highlighting its significant academic contribution. Notably, its Scopus ranking places it in the top 31% of its category, underscoring the relevance and quality of the research it publishes. With a commitment to advancing knowledge, this journal not only promotes accessibility through its Open Access model but also ensures that cutting-edge studies are readily available to those dedicated to improving geriatric care. Located in Auckland, New Zealand, the journal continues to expand its influence globally, making it an essential platform for discussions surrounding aging and health.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
Navigating the future of gerontology and geriatrics.ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, published by SPRINGER HEIDELBERG, is an authoritative journal dedicated to advancing the field of geriatrics and gerontology. With its ISSN 0948-6704 and E-ISSN 1435-1269, this journal has been a significant source of scholarly articles since its inception in 1995, catering to researchers and practitioners amid the growing importance of ageing studies. While it currently holds a Q4 ranking in Geriatrics and Gerontology and a Q3 ranking in Gerontology and Social Sciences, its contribution spans vital topics related to health ethics and legal aspects—reflecting a comprehensive view of the challenges faced in elder care. Although it is not an open-access journal, its rigorous peer-review process ensures that the research published is of high quality and relevance. Based in Heidelberg, Germany, the journal aims to foster discourse and disseminate crucial research findings that impact the health of elderly populations, making it an essential resource for researchers, healthcare professionals, and students devoted to improving geriatric care and understanding the complexities associated with ageing.
Geriatrics & Gerontology International
Enhancing Lives Through Geriatric ResearchGeriatrics & Gerontology International, published by WILEY, is a prestigious academic journal dedicated to advancing the field of geriatric and gerontological research. With a strong focus on the interdisciplinary aspects of aging, this journal has established itself as a leading source of high-quality research, reflected in its impressive impact factor and 2023 Scopus rankings, including a Q1 status in Health (Social Science) and Q2 in both Geriatrics and Gerontology. Since its inception in 2004 and continuous publication from 2008 to 2024, it has fostered a vibrant exchange of ideas among researchers, clinicians, and students alike. The journal serves as a critical resource for innovative studies, reviews, and commentaries that help shape policies and practices affecting the elderly population. It is essential reading for those dedicated to improving the quality of life for older adults and contributes significantly to the understanding of the complexities surrounding aging.
Current Geriatrics Reports
Empowering research to enhance the lives of the aging population.Current Geriatrics Reports is a pivotal journal published by SPRINGER, dedicated to disseminating cutting-edge research and insights in the dynamic field of geriatrics and gerontology. Launched in 2014 and ongoing until 2024, this journal plays a critical role in addressing the complex needs and challenges faced by the aging population. Although it currently holds a Q4 quartile ranking in its category and occupies the 84th position out of 116 in the Scopus metrics for Medicine, Geriatrics, and Gerontology, it serves as a vital platform for emerging research that shapes clinical practices and policy-making. Researchers, professionals, and students alike will find Current Geriatrics Reports to be an invaluable resource for staying updated on advancements, best practices, and innovations in geriatric care. While the journal is not open access, it continues to impact the field significantly and enrich contemporary discussions surrounding aging.
Journal of Gerontology and Geriatrics
Advancing Knowledge on Aging and Geriatric HealthJournal of Gerontology and Geriatrics, published by PACINI EDITORE, is a crucial resource for those dedicated to the study of aging and geriatric health. Since its inception in 2016, this journal has aimed to disseminate high-quality research and findings that address the intricate biological, social, and psychological aspects of aging. With ISSN 2499-6564 and E-ISSN 2499-6564, it strives to foster discussions that enhance our understanding of gerontology and geriatrics on a global scale, despite its current positioning in the Q4 quartile of academic rankings. Located in Pisa, Italy, the journal invites contributions from researchers, professionals, and students who are passionate about advancing knowledge in these critical fields. Although it currently does not offer open access, the journal plays a vital role in connecting the community with essential insights that guide both research and practice in geriatric care.
Expert Opinion On Drug Safety
Fostering Scholarly Dialogue on Drug SafetyExpert Opinion on Drug Safety is a prestigious academic journal dedicated to advancing knowledge in the fields of drug safety and pharmacology. Published by Taylor & Francis Ltd, this journal serves as an essential resource for researchers and professionals seeking to explore the complexities of drug interactions, adverse effects, and risk management. With an impressive impact factor and recognized as a Q1 journal in both the Medicine (Miscellaneous) and Pharmacology (Medical) categories, it ranks favorably at #78 out of 272 in Scopus, placing it in the 71st percentile among its peers. Operating under a rigorous peer-review process, the journal publishes original research, expert reviews, and opinion pieces that contribute to a deeper understanding of drug safety practices. While not an open access journal, it remains a vital platform for disseminating pivotal findings and fostering scholarly dialogue, ensuring that critical insights reach a global audience. With continuous publication from 2002 to 2024, Expert Opinion on Drug Safety is a key reference for anyone involved in pharmaceutical research, healthcare practice, or drug regulation.
ACTA PHARMACEUTICA
Unlocking the potential of pharmaceutical research for all.ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.
Journal of Pharmaceutical Health Care and Sciences
Catalyzing advancements in healthcare through rigorous research.The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.
European Journal of Geriatrics and Gerontology
Fostering collaboration in geriatric and gerontological studies.Welcome to the European Journal of Geriatrics and Gerontology, a peer-reviewed platform dedicated to advancing knowledge and research in the fields of geriatrics and gerontology. Published by GALENOS PUBL HOUSE, this journal serves as a critical resource for researchers, healthcare professionals, and students who are involved in the care, treatment, and study of elderly populations. Since its inception in 2019 and running through 2024, the journal aims to foster interdisciplinary collaboration and disseminate innovative research that addresses the unique challenges faced by older adults. With an ISSN of 2687-2625, the journal is classified in the Q4 quartile of the Geriatrics and Gerontology category, signifying its emerging influence within the academic community, despite its current Scopus ranking of #113 out of 116, reflecting a rich opportunity for growth and visibility. Although the journal is not open access, it maintains a commitment to scholarly rigor and quality. Engage with the European Journal of Geriatrics and Gerontology to contribute to and learn from the evolving discourse in aging research.